Floatz logo

BISMUTH SALICYLATE

Helicobacter Pylori Infection

Fatih Sultan Mehmet Training and Research HospitalSmall moleculePhase 4 / ApprovedDormant
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
89/ 100

Competitive context

2 Active assets in the Helicobacter Pylori Infection cohort.

Asset / SponsorPhaseRating
Orelabrutinib
Fudan University
Phase 2CCC
Huazhi Rougan Granule
Nanjing First Hospital, Nanjing Medical University
N/AD

Same molecule, other indications

BISMUTH SALICYLATE is also rated in:

morbid obesityDormant
BB
Indicative ·
65 / 100
View asset →
lymphomaDormant
CCC
Indicative ·
51 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →